Table A1.
Reasons for Excluding Patients
| Reason | No. of Patients
|
||
|---|---|---|---|
| CVD | BCT | Total | |
| Ineligible patients | |||
| No histologic documentation | 1 | 1 | |
| Missing baseline tests | 5 | 2 | 7 |
| Baseline brain metastases | 1 | 1 | |
| Baseline measurements > 4 weeks before randomization | 3 | 3 | |
| Inadequate PFTs | 2 | 1 | 3 |
| Low PS | 1 | 1 | |
| Low baseline hemoglobin | 1 | 1 | |
| Prior IL-2 | 1 | 1 | |
| Prior chemotherapy | 1 | 1 | |
| Immunotherapy within 4 wks | 1 | 1 | |
| Total | 10 | 10 | 20 |
| Failure to start assigned therapy | |||
| Decrease in PS | 2 | 2 | |
| Treatment refusal | 3 | 1 | 4 |
| No insurance coverage | 2 | 2 | |
| Total | 3 | 5 | 8 |
Abbreviations: CVD, cisplatin, vinblastine, and dacarbazine; BCT, biochemotherapy; PFTs, pulmonary function tests; PS, performance status; IL-2, interleukin-2.